Cargando…
Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells()
Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults. Current therapy includes surgery, radiation and chemotherapy with temozolomide (TMZ). Major determinants of clinical response to TMZ include methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) pro...
Autores principales: | Cui, Bo, Johnson, Stewart P., Bullock, Nancy, Ali-Osman, Francis, Bigner, Darell D., Friedman, Henry S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596690/ https://www.ncbi.nlm.nih.gov/pubmed/23554659 http://dx.doi.org/10.1016/S1674-8301(10)60057-7 |
Ejemplares similares
-
Mifepristone Overcomes Tumor Resistance to Temozolomide Associated with DNA Damage Repair and Apoptosis in an Orthotopic Model of Glioblastoma
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2018) -
Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair
por: Wu, Jianheng, et al.
Publicado: (2021) -
Transcriptomic Profiling of DNA Damage Response in Patient-Derived Glioblastoma Cells before and after Radiation and Temozolomide Treatment
por: Lozinski, Mathew, et al.
Publicado: (2022) -
Commentary: Kinesin Family Member C1 Increases Resistance of Glioblastoma to Temozolomide Through Promoting DNA Damage Repair
por: Yang, Liu, et al.
Publicado: (2022) -
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O(6)-methylguanine DNA damage in glioblastoma
por: Wu, Shaofang, et al.
Publicado: (2021)